Northern Trust’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.08M Sell
283,138
-34,402
-11% -$131K ﹤0.01% 3341
2025
Q1
$835K Sell
317,540
-6,686
-2% -$17.6K ﹤0.01% 3357
2024
Q4
$1.15M Buy
324,226
+69,092
+27% +$245K ﹤0.01% 3331
2024
Q3
$1.16M Buy
255,134
+7,212
+3% +$32.9K ﹤0.01% 3297
2024
Q2
$1.08M Sell
247,922
-16,887
-6% -$73.5K ﹤0.01% 3213
2024
Q1
$1.33M Sell
264,809
-4,227
-2% -$21.2K ﹤0.01% 3179
2023
Q4
$1.69M Buy
269,036
+56
+0% +$351 ﹤0.01% 3088
2023
Q3
$1.92M Buy
268,980
+9,803
+4% +$69.8K ﹤0.01% 2963
2023
Q2
$2.64M Buy
259,177
+195,525
+307% +$1.99M ﹤0.01% 2849
2023
Q1
$577K Buy
63,652
+14,333
+29% +$130K ﹤0.01% 3404
2022
Q4
$354K Sell
49,319
-264
-0.5% -$1.89K ﹤0.01% 3616
2022
Q3
$323K Buy
49,583
+1,477
+3% +$9.62K ﹤0.01% 3655
2022
Q2
$232K Sell
48,106
-802
-2% -$3.87K ﹤0.01% 3854
2022
Q1
$278K Sell
48,908
-802
-2% -$4.56K ﹤0.01% 3985
2021
Q4
$249K Sell
49,710
-400
-0.8% -$2K ﹤0.01% 4107
2021
Q3
$333K Buy
50,110
+225
+0.5% +$1.5K ﹤0.01% 3931
2021
Q2
$305K Sell
49,885
-64,988
-57% -$397K ﹤0.01% 3925
2021
Q1
$764K Sell
114,873
-24,484
-18% -$163K ﹤0.01% 3687
2020
Q4
$737K Sell
139,357
-6,498
-4% -$34.4K ﹤0.01% 3618
2020
Q3
$1.09M Buy
145,855
+37,177
+34% +$277K ﹤0.01% 3364
2020
Q2
$799K Buy
+108,678
New +$799K ﹤0.01% 3425
2019
Q4
Sell
-10,426
Closed -$62K 4292
2019
Q3
$62K Sell
10,426
-56,144
-84% -$334K ﹤0.01% 4023
2019
Q2
$213K Sell
66,570
-2,093
-3% -$6.7K ﹤0.01% 3811
2019
Q1
$206K Sell
68,663
-251
-0.4% -$753 ﹤0.01% 3774
2018
Q4
$259K Buy
68,914
+82
+0.1% +$308 ﹤0.01% 3724
2018
Q3
$404K Buy
68,832
+900
+1% +$5.28K ﹤0.01% 3678
2018
Q2
$384K Buy
67,932
+19,947
+42% +$113K ﹤0.01% 3663
2018
Q1
$595K Buy
+47,985
New +$595K ﹤0.01% 3520